» Articles » PMID: 11024397

Comparison of Platelet Activation in Unstable and Stable Angina Pectoris and Correlation with Coronary Angiographic Findings

Overview
Journal Am J Cardiol
Date 2000 Oct 12
PMID 11024397
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

We sought to investigate the relation between platelet activation and the angiographic evidence of ruptured plaque in patients presenting with unstable and stable angina pectoris. We prospectively enrolled 25 consecutive patients (5 women and 20 men, mean age 62 +/- 3 years), 17 with unstable angina and 8 with stable angina. Systemic venous blood samples were collected within 4 to 6 hours of admission for flow cytometry analysis. Activation-dependent epitope CD63 and glycoprotein IIb/IIIa on the platelet membrane were assayed. Fibrinogen levels were also measured. All patients with unstable angina underwent cardiac catheterization and had angiographic evidence of ruptured plaque. Of the patients with stable angina, 5 underwent coronary angiography with smooth noncomplex lesions and 3 had negative technetium-99m sestamibi stress tests. Patients with unstable angina were characterized by 39% higher levels of fibrinogen than patients with stable angina (423 +/- 304 vs 304 +/- 51 mg/dl, p = 0.004). The percentage of platelets positive for the activation-dependent epitope CD63 was 5 times higher in patients with unstable than stable angina (14.6 +/- 5.6% vs 2.75 +/- 1.6%, p = 0.0026). They also had a 15% higher expression of their glycoprotein IIb/IIIa (517 +/- 79 vs 449 +/- 50 mean fluorescence intensity, p = 0.038). Thus, this study establishes a direct relation between the morphology of ruptured plaque and platelet activation in patients with unstable angina. This may allow for further risk stratification. Patients with unstable complex lesions had a fivefold higher expression of the platelet activation epitope CD63 than patients with stable angina. Furthermore, they had 15% more glycoprotein IIb/IIIa aggregation sites expressed on their platelet membrane, thus indicating an intense thrombogenic potential.

Citing Articles

A review on the functional characteristics of the c-Myeloproliferative Leukaemia (c-MPL) gene and its isoforms.

Hussain M, Das S, Kulkarni M, Laha S Cell Oncol (Dordr). 2024; 47(5):1607-1626.

PMID: 39283476 DOI: 10.1007/s13402-024-00988-w.


Hypoxia-associated genes predicting future risk of myocardial infarction: a GEO database-based study.

Li S, Zhang J, Ni J, Cao J Front Cardiovasc Med. 2023; 10:1068782.

PMID: 37465452 PMC: 10351911. DOI: 10.3389/fcvm.2023.1068782.


Investigating the multi-target pharmacological mechanism of danhong injection acting on unstable angina by combined network pharmacology and molecular docking.

Guo S, Wu J, Zhou W, Liu X, Zhang J, Jia S BMC Complement Med Ther. 2020; 20(1):66.

PMID: 32122353 PMC: 7076845. DOI: 10.1186/s12906-020-2853-5.


Nicorandil effects on platelet function, Hs-CRP, MMP-9 and myocardial antioxidation in patients with unstable angina.

Peng R, Yang X, Liang X Exp Ther Med. 2019; 18(4):3095-3099.

PMID: 31572549 PMC: 6755476. DOI: 10.3892/etm.2019.7918.


Detection of high-risk atherosclerotic plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa receptor on activated platelets.

Guo S, Shen S, Wang J, Wang H, Li M, Liu Y Theranostics. 2015; 5(4):418-30.

PMID: 25699100 PMC: 4329504. DOI: 10.7150/thno.10020.